Skip to main content
Top
Published in: Reactions Weekly 1/2023

01-06-2023 | Neuromyelitis Optica Spectrum Disease | Case report

Immunosuppressants/inebilizumab/tozinameran

COVID-19 infection and pain on site of application: 12 case reports

Published in: Reactions Weekly | Issue 1/2023

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Metadata
Title
Immunosuppressants/inebilizumab/tozinameran
COVID-19 infection and pain on site of application: 12 case reports
Publication date
01-06-2023
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-41891-7

Other articles of this Issue 1/2023

Reactions Weekly 1/2023 Go to the issue

Case report

Dolutegravir